Mucomyst (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucomyst, is a mucolytic presented as an oral formulation for oral use. It reduces mucus viscosity and is employed to facilitate expectoration in chronic bronchitis, chronic obstructive pulmonary disease, and respiratory tract infections in adult patients.

GNH USA supplies Mucomyst as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable delivery across multiple regions, and supporting local healthcare initiatives through continuous technical support and training.

Acetylcysteine is a mucolytic agent used to thin respiratory secretions in various pulmonary conditions.

Chronic bronchitis: Improves mucus clearance and reduces cough frequency. COPD: Facilitates expectoration and eases breathing difficulty. Respiratory tract infections: Helps loosen thick secretions to aid recovery.

Acetylcysteine may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis after oral intake. - Diarrhea: loose stools in some patients. - Abdominal discomfort: cramping or pain. - Headache: transient mild headache. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe bronchospasm: worsening respiratory difficulty. - Angioedema: swelling of face, lips, or throat. - Hepatic dysfunction: abnormal liver enzymes. - Stevens‑Johnson syndrome: severe skin reaction. - Severe rash or exfoliative dermatitis.

When prescribing Acetylcysteine, consider the following precautions.

Assess renal function: adjust use in patients with severe renal impairment. Monitor for bronchospasm: observe for worsening respiratory symptoms. Avoid in known hypersensitivity: discontinue if allergic reaction occurs. Use with caution in asthma: may provoke bronchoconstriction. Adjust dose in hepatic impairment: consider liver function status. Store at below 25°C: keep in the original pack, protect from moisture.

Acetylcysteine can interact with several medicines; monitor accordingly.

Major Interactions (Avoid): - Nitroprusside: concurrent use may potentiate hypotensive effects. - Activated charcoal: may reduce acetylcysteine absorption if given simultaneously.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): acetylcysteine may enhance anticoagulant effect. - Carbamazepine: possible increase in carbamazepine plasma levels. - Certain antibiotics (e.g., fluoroquinolones): may increase risk of gastrointestinal upset.